Institutional investors hold a majority ownership of ZGNX through the 53.25% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2014, these large investors purchased a net $3.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 9.4 Million shares of Zogenix Inc
BROADFIN CAPITAL LLC Bought 600.0 Thousand shares of Zogenix Inc
ALYESKA INVESTMENT GROUP LP Bought 488.5 Thousand shares of Zogenix Inc